AS
Altshuler Shaham’s Teva Pharmaceuticals TEVA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $14.3M | Buy |
854,157
+159,580
| +23% | +$2.68M | 0.46% | 22 |
|
|
2025
Q1 | $10.6M | Buy |
694,577
+498,314
| +254% | +$7.58M | 0.26% | 22 |
|
|
2024
Q4 | $4.36M | Sell |
196,263
-25,267
| -11% | -$561K | 0.15% | 26 |
|
|
2024
Q3 | $3.96M | Sell |
221,530
-56,390
| -20% | -$1.01M | 0.24% | 23 |
|
|
2024
Q2 | $4.52M | Buy |
277,920
+30,530
| +12% | +$497K | 0.15% | 19 |
|
|
2024
Q1 | $3.48M | Buy |
247,390
+122,709
| +98% | +$1.72M | 0.14% | 16 |
|
|
2023
Q4 | $1.31M | Sell |
124,681
-35,149
| -22% | -$370K | 0.07% | 33 |
|
|
2023
Q3 | $1.61M | Sell |
159,830
-151,035
| -49% | -$1.53M | 0.04% | 35 |
|
|
2023
Q2 | $2.35M | Sell |
310,865
-5,517
| -2% | -$41.7K | 0.04% | 31 |
|
|
2023
Q1 | $2.8M | Buy |
316,382
+236,432
| +296% | +$2.09M | 0.06% | 26 |
|
|
2022
Q4 | $750K | Buy |
+79,950
| New | +$750K | 0.03% | 48 |
|
|
2021
Q3 | – | Sell |
-1,320
| Closed | -$13K | – | 651 |
|
|
2021
Q2 | $13K | Buy |
+1,320
| New | +$13K | ﹤0.01% | 531 |
|
|
2020
Q2 | – | Sell |
-45
| Closed | – | – | 552 |
|
|
2020
Q1 | $0 | Hold |
45
| – | – | ﹤0.01% | 602 |
|
|
2019
Q4 | $0 | Buy |
+45
| New | – | ﹤0.01% | 613 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 292 |
|
|
2018
Q2 | – | Hold |
0
| – | – | – | 255 |
|
|
2018
Q1 | – | Sell |
-29,031
| Closed | -$506K | – | 223 |
|
|
2017
Q4 | $506K | Buy |
+29,031
| New | +$506K | 0.07% | 83 |
|